Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232750 · ClinicalTrials.gov registry record
Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 1,320
- Enrollment target
NCT02232750 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 1,320 participants.
The verdict
NCT02232750 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 1,320 participants
- Enrollment target
Study Summary
The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2014-07-14 |
| Est. Completion | 2015-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02232750
The ClinicalTrials.gov registry entry for NCT02232750 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02232750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02232750 about?
NCT02232750 is a clinical study titled "Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)". The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated tod...
What is the current status of trial NCT02232750?
This trial is currently completed. The enrollment target is 1,320 participants. The study started on 2014-07-14. Estimated completion is 2015-08-15.
Who is sponsoring clinical trial NCT02232750?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.